Clinical Trial Update: Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency: [Phase 3]

View source ↗

Summary

A Phase 3 trial of dichloroacetate for Pyruvate Dehydrogenase Complex Deficiency is ongoing. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyruvate Dehydrogenase Complex Deficiency

Drugs mentioned

• Dichloroacetate (dichloroacetate)

Snippet

Sponsor: Saol Therapeutics Inc | Conditions: Pyruvate Dehydrogenase Complex Deficiency | Phase 3 | Status: ACTIVE_NOT_RECRUITING